US Stock MarketDetailed Quotes

TCRT Alaunos Therapeutics

Watchlist

2.2300
+0.1000+4.69%

Trading Nov 21 13:06 ET

3.57MMarket Cap-301P/E (TTM)

Alaunos Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

87.75%-781K

75.99%-1.68M

79.57%-1.92M

-3.11%-30.14M

-3.58%-7.39M

-3.73%-6.37M

14.47%-7M

-20.73%-9.38M

52.44%-29.23M

52.86%-7.13M

Net income from continuing operations

86.70%-1.13M

87.14%-1.13M

83.26%-1.68M

6.86%-35.14M

14.37%-7.84M

4.24%-8.48M

11.67%-8.77M

-2.66%-10.05M

52.09%-37.73M

22.34%-9.16M

Operating gains losses

----

0.00%7K

---5K

--2K

----

--7K

----

Depreciation and amortization

--0

-99.86%1K

-99.71%2K

-16.09%2.32M

-65.27%241K

-1.74%679K

2.04%699K

1.02%696K

6.24%2.76M

-1.56%694K

Other non cash items

----

-0.52%1.33M

25.39%-1.1M

13.57%385K

-30.33%1.46M

54.76%585K

4,203.23%1.33M

-457.52%-1.47M

Change In working capital

137.95%266K

49.85%-656K

73.16%-409K

-818.85%-6.25M

-241.42%-2.72M

-180.76%-701K

35.25%-1.31M

-1,655.10%-1.52M

-72.30%870K

131.51%1.92M

-Change in receivables

0.00%4K

25.00%-3K

--0

-99.73%3K

-100.03%-1K

100.14%4K

---4K

-99.64%4K

-68.86%1.11M

626.75%2.91M

-Change in prepaid assets

173.66%344K

-195.81%-320K

526.53%307K

-256.52%-1.36M

-2,646.00%-1.27M

-193.21%-467K

100.00%334K

-67.11%49K

-90.56%867K

-96.76%50K

-Change in payables and accrued expense

76.23%-82K

40.64%-333K

50.42%-716K

-587.16%-4.76M

14.89%-2.41M

-110.14%-345K

-96.84%-561K

-47.80%-1.44M

93.23%-693K

62.57%-2.83M

-Change in other current assets

----

281.68%500K

----

-34.83%131K

--0

-Change in other current liabilities

--0

-17.71%-638K

-74.18%465K

185.60%107K

46.89%-1.08M

30.00%-133K

-224.88%-542K

1,159.41%1.8M

Cash from discontinued investing activities

Operating cash flow

87.75%-781K

75.99%-1.68M

79.57%-1.92M

-3.11%-30.14M

-3.58%-7.39M

-3.73%-6.37M

14.47%-7M

-20.73%-9.38M

52.44%-29.23M

52.86%-7.13M

Investing cash flow

Cash flow from continuing investing activities

797.41%1.35M

1,716.13%1.5M

107.14%1K

-136.84%-135K

20.69%-23K

94.19%-193K

74.09%-93K

Net PPE purchase and sale

--0

797.41%1.35M

1,716.13%1.5M

107.14%1K

-136.84%-135K

20.69%-23K

94.19%-193K

74.09%-93K

Cash from discontinued investing activities

Investing cash flow

--0

797.41%1.35M

1,716.13%1.5M

107.14%1K

-136.84%-135K

20.69%-23K

94.19%-193K

74.09%-93K

Financing cash flow

Cash flow from continuing financing activities

-384.88%-18.14M

-11.98M

-6.16M

-75.30%6.37M

4,655.91%8.47M

Net issuance payments of debt

--0

-117.27%-18.11M

--0

---11.86M

---6.25M

-133.33%-8.33M

---6.25M

Net common stock issuance

--0

-99.37%92K

--0

--92K

--14.68M

--14.72M

Proceeds from stock option exercised by employees

----

--0

----

-97.97%21K

--0

Net other financing activities

----

---125K

--0

----

Cash from discontinued financing activities

Financing cash flow

--0

-384.88%-18.14M

--0

---11.98M

---6.16M

-75.30%6.37M

4,655.91%8.47M

Net cash flow

Beginning cash position

-86.55%2.46M

-88.93%4.15M

-88.56%6.06M

-30.32%53M

-76.92%11.94M

-69.48%18.32M

-45.16%37.43M

-30.32%53M

-33.91%76.05M

-43.59%51.75M

Current changes in cash

87.75%-781K

91.21%-1.68M

87.68%-1.92M

-103.55%-46.93M

-570.18%-5.88M

22.90%-6.37M

-131.89%-19.12M

-99.54%-15.56M

40.90%-23.06M

107.98%1.25M

End cash Position

-85.91%1.68M

-86.55%2.46M

-88.93%4.15M

-88.56%6.06M

-76.92%11.94M

-69.48%18.32M

-45.16%37.43M

-30.32%53M

Free cash flow

87.75%-781K

76.45%-1.68M

79.70%-1.92M

-3.03%-30.34M

-1.92%-7.39M

-3.51%-6.38M

13.43%-7.14M

-21.07%-9.44M

54.55%-29.45M

53.21%-7.25M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	87.75%-781K	75.99%-1.68M	79.57%-1.92M	-3.11%-30.14M	-3.58%-7.39M	-3.73%-6.37M	14.47%-7M	-20.73%-9.38M	52.44%-29.23M	52.86%-7.13M
Net income from continuing operations	86.70%-1.13M	87.14%-1.13M	83.26%-1.68M	6.86%-35.14M	14.37%-7.84M	4.24%-8.48M	11.67%-8.77M	-2.66%-10.05M	52.09%-37.73M	22.34%-9.16M
Operating gains losses	----	----	----	0.00%7K	---5K	--2K	----	----	--7K	----
Depreciation and amortization	--0	-99.86%1K	-99.71%2K	-16.09%2.32M	-65.27%241K	-1.74%679K	2.04%699K	1.02%696K	6.24%2.76M	-1.56%694K
Other non cash items	----	----	----	-0.52%1.33M	25.39%-1.1M	13.57%385K	-30.33%1.46M	54.76%585K	4,203.23%1.33M	-457.52%-1.47M
Change In working capital	137.95%266K	49.85%-656K	73.16%-409K	-818.85%-6.25M	-241.42%-2.72M	-180.76%-701K	35.25%-1.31M	-1,655.10%-1.52M	-72.30%870K	131.51%1.92M
-Change in receivables	0.00%4K	25.00%-3K	--0	-99.73%3K	-100.03%-1K	100.14%4K	---4K	-99.64%4K	-68.86%1.11M	626.75%2.91M
-Change in prepaid assets	173.66%344K	-195.81%-320K	526.53%307K	-256.52%-1.36M	-2,646.00%-1.27M	-193.21%-467K	100.00%334K	-67.11%49K	-90.56%867K	-96.76%50K
-Change in payables and accrued expense	76.23%-82K	40.64%-333K	50.42%-716K	-587.16%-4.76M	14.89%-2.41M	-110.14%-345K	-96.84%-561K	-47.80%-1.44M	93.23%-693K	62.57%-2.83M
-Change in other current assets	----	----	----	281.68%500K	----	----	----	----	-34.83%131K	--0
-Change in other current liabilities	--0	--0	--0	-17.71%-638K	-74.18%465K	185.60%107K	46.89%-1.08M	30.00%-133K	-224.88%-542K	1,159.41%1.8M
Cash from discontinued investing activities
Operating cash flow	87.75%-781K	75.99%-1.68M	79.57%-1.92M	-3.11%-30.14M	-3.58%-7.39M	-3.73%-6.37M	14.47%-7M	-20.73%-9.38M	52.44%-29.23M	52.86%-7.13M
Investing cash flow
Cash flow from continuing investing activities	0	0	0	797.41%1.35M	1,716.13%1.5M	107.14%1K	-136.84%-135K	20.69%-23K	94.19%-193K	74.09%-93K
Net PPE purchase and sale	--0	--0	--0	797.41%1.35M	1,716.13%1.5M	107.14%1K	-136.84%-135K	20.69%-23K	94.19%-193K	74.09%-93K
Cash from discontinued investing activities
Investing cash flow	--0	--0	--0	797.41%1.35M	1,716.13%1.5M	107.14%1K	-136.84%-135K	20.69%-23K	94.19%-193K	74.09%-93K
Financing cash flow
Cash flow from continuing financing activities	0	0	0	-384.88%-18.14M	0	0	-11.98M	-6.16M	-75.30%6.37M	4,655.91%8.47M
Net issuance payments of debt	--0	--0	--0	-117.27%-18.11M	--0	--0	---11.86M	---6.25M	-133.33%-8.33M	---6.25M
Net common stock issuance	--0	--0	--0	-99.37%92K	--0	--0	--0	--92K	--14.68M	--14.72M
Proceeds from stock option exercised by employees	----	----	----	--0	----	----	----	----	-97.97%21K	--0
Net other financing activities	----	----	----	---125K	--0	--0	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	--0	--0	--0	-384.88%-18.14M	--0	--0	---11.98M	---6.16M	-75.30%6.37M	4,655.91%8.47M
Net cash flow
Beginning cash position	-86.55%2.46M	-88.93%4.15M	-88.56%6.06M	-30.32%53M	-76.92%11.94M	-69.48%18.32M	-45.16%37.43M	-30.32%53M	-33.91%76.05M	-43.59%51.75M
Current changes in cash	87.75%-781K	91.21%-1.68M	87.68%-1.92M	-103.55%-46.93M	-570.18%-5.88M	22.90%-6.37M	-131.89%-19.12M	-99.54%-15.56M	40.90%-23.06M	107.98%1.25M
End cash Position	-85.91%1.68M	-86.55%2.46M	-88.93%4.15M	-88.56%6.06M	-88.56%6.06M	-76.92%11.94M	-69.48%18.32M	-45.16%37.43M	-30.32%53M	-30.32%53M
Free cash flow	87.75%-781K	76.45%-1.68M	79.70%-1.92M	-3.03%-30.34M	-1.92%-7.39M	-3.51%-6.38M	13.43%-7.14M	-21.07%-9.44M	54.55%-29.45M	53.21%-7.25M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	--	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data